Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
- PMID: 30107604
- PMCID: PMC6097838
- DOI: 10.1093/jnen/nly056
Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
Abstract
Immunohistochemical (IHC) α-synuclein (Asyn) pathology in peripheral biopsies may be a biomarker of Parkinson disease (PD). The multi-center Systemic Synuclein Sampling Study (S4) is evaluating IHC Asyn pathology within skin, colon and submandibular gland biopsies from 60 PD and 20 control subjects. Asyn pathology is being evaluated by a blinded panel of specially trained neuropathologists. Preliminary work assessed 2 candidate immunoperoxidase methods using a set of PD and control autopsy-derived sections from formalin-fixed, paraffin-embedded blocks of the 3 tissues. Both methods had 100% specificity; one, utilizing the 5C12 monoclonal antibody, was more sensitive in skin (67% vs 33%), and was chosen for further use in S4. Four trainee neuropathologists were trained to perform S4 histopathology readings; in subsequent testing, their scoring was compared to that of the trainer neuropathologist on both glass slides and digital images. Specificity and sensitivity were both close to 100% with all readers in all tissue types on both glass slides and digital images except for skin, where sensitivity averaged 75% with digital images and 83.5% with glass slides. Semiquantitative (0-3) density score agreement between trainees and trainer averaged 67% for glass slides and 62% for digital images.
Figures



References
-
- Simonsen AH, Kuiperij B, El-Agnaf OM, et al. The utility of alpha-synuclein as biofluid marker in neurodegenerative diseases: A systematic review of the literature. Biomarkers Med 2016;10:19–34 - PubMed
-
- Mollenhauer B, Parnetti L, Rektorova I, et al. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson’s disease and related disorders. J Neurochem 2016;139 (Suppl. 1):290–317 - PubMed
-
- Catafau AM, Bullich S.. Non-amyloid PET imaging biomarkers for neurodegeneration: Focus on tau, alpha-synuclein and neuroinflamation. Curr Alzheimer Res 2016;14:169–77 - PubMed
-
- Rajput AH, Rozdilsky B, Rajput A.. Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci 1991;18:275–8 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical